HTH17MAG-14K

MILLIPLEX^® Human Th17 Panel

Configurable Human Th17 25-Plex Panel

• Synonym(s): Human Th17 cytokine multiplex kit, Luminex^® human Th17 cytokine immunoassay, Millipore human Th17 cytokine panel
• UNSPSC Code: 12161503
• NACRES: NA.84
• eCl@ss: 32161000

Properties

• Product Name: MILLIPLEX^® Human Th17 Panel, Configurable Human Th17 25-Plex Panel
• species reactivity: human
• Quality Level: 200
• packaging: pkg of 1 ea
• manufacturer/tradename: Milliplex^®
• assay range: accuracy: 79-107%; standard curve range: 1-5000 pg/mL; (IL-10); standard curve range: 10-40,000 pg/mL; (IFNγ); standard curve range: 12-50,000 pg/mL; (IL-17A & IL-2); standard curve range: 24-100,000 pg/mL; (IL-17 & IL-4); standard curve range: 3-10,000 pg/mL; (IL-6 & TNFα); standard curve range: 336-1,500,000 pg/mL; (IL-23); standard curve range: 37-150,000 pg/mL; (IL-22 & TNFβ); standard curve range: 488-2,000,000 pg/mL; (IL-17E/IL-25); standard curve range: 49-200,000 pg/mL; (IL-28a & IL-31); standard curve range: 5-20,000 pg/mL; (MIP-3α, IL-1β, IL-12 (p70), IL-15, IL-21 & IL-33); standard curve range: 6-25,000 pg/mL; (IL-5); standard curve range: 61-250,000 pg/mL; (GM-CSF & IL-27); standard curve range: 7-30,000 pg/mL; (IL-13); standard curve range: 9-35,000 pg/mL; (IL-9)
• technique(s): multiplexing: suitable
• input: cell culture supernatant; serum
• detection method: fluorometric (Luminex^® xMAP^® technology)
• shipped in: wet ice
• storage temp.: 2-8°C

Description

Legal Information

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

Application

MILLIPLEX^® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 25 analytes in human serum, plasma, and cell culture supernatants.Analytes included: GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-17F, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-27, IL-28A, IL-31, IL-33, MIP-3α/CCL20, TNF-α, TNFβAssay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Disclaimer

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Features and Benefits

Comprehensive 25-Plex Panel: Simultaneously quantifies 25 Th17-related cytokines and chemokines including IL-17A, IL-17F, IL-21, IL-22, IL-23, TNF-α, and more.Multiplexing with Luminex^® xMAP Technology: Enables high-throughput analysis of multiple biomarkers in a single 25 µL sample, saving time and resources.Verified for Multiple Sample Types: Compatible with human serum, plasma, and cell culture supernatants, offering flexibility for various research models.Optimized Serum Matrix: Mimics native analyte environments for more physiologically relevant results.Supports Autoimmune and Cancer Research: Ideal for studying Th17 involvement in diseases like multiple sclerosis, rheumatoid arthritis, Crohn′s disease, and tumor progression.

General description

CD4 T-helper cells are major players in adaptive immunity. Based on their expression profile of transcription factors and secreted cytokines, these cells are divided into the major subsets Th1, Th2, Th17 and T regulatory (Treg) cells. Th1 cells, induced by IL-12 and enhanced by IFNγ, secrete IFNγ that activates macrophages. Induced by IL-4, Th2 cells primarily produce IL-4, IL-5, IL-13, IL-25 and IL-17E, playing a role in allergy. Treg cells, induced by TGFβ, produce the anti-inflammatory cytokines IL-10 and TGFβ and function to control T-cell responses to prevent autoimmune reactions. Th17 cells, a more recently discovered subset characterized by the production of IL-17, are induced by TGFβ combined with IL-23 and IL-1β in humans, and TGFβ, IL-6 and IL-21 in mice. Activated Th17 cells secrete IL-17A, IL-17F, IL-21, IL-22 and TNFα to promote tissue inflammation. Th17 cells are involved in the clearance of extracellular bacteria and fungi. They are abundant in the intestinal lamina propria and function as a barrier against invading pathogens. Excessive amounts of Th17 cells have been implicated in the pathogenesis of several autoimmune diseases, including multiple sclerosis, psoriasis, juvenile diabetes, rheumatoid arthritis, Crohn′s disease, and autoimmune uveitis. In addition, Th17 cells play an important role in tumor development, progression, and metastasis, potentially in both promoting and inhibiting tumor growth.

Safety Information

• pictograms: GHS08,GHS05,GHS07,GHS09
• signalword: Danger
• hcodes: H302 + H312 + H332,H317,H318,H373,H411
• pcodes: P273 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P314
• Hazard Classifications: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
• target_organs: Respiratory Tract
• Storage Class: 10 - Combustible liquids